IL-10’s impact extends beyond mere support for tumor cell survival; it has been implicated in promoting the stemness of leukemia stem cells via IL10/IL10R/PI3K/AKT signaling pathway, thereby potentially perpetuating disease relapse and resistance to therapy42. Here, AKT1 is linked to leukemia.